$PFE - EARNINGS JUST RELEASED -
Added 2024-10-29 11:34:04 +0000 UTC$PFE have beaten their EPS estimates by a whopping +72%
We said yesterday that the management needed to deliver and this is it.
What we need to see next is a break above the triangle at $29.50 and I believe this can come this week, a break and hold above this level and you have a buy signal and I will add again.
PFE Pfizer raises 2024 guidance, stock up 2% pre
- Est adjusted EPS $2.75 to $2.95, saw $2.45 to $2.65
- Est revenue $61.0 billion to $64.0 billion, saw $59.5 billion to $62.5 billion 3Q24 Results (beat)
- Adj EPS $1.06, est $0.62 - Revenue $17.70bn, estimate $15.08bn
- Comirnaty revenue $1.42bn, est $1.24bn
- Prevnar franchise rev $1.80bn, est $1.77bn
- Ibrance rev $1.09bn, -13% y/y, estimate $1.12bn
- Eliquis revenue $1.62bn, est $1.59bn
- Vyndaqel family rev $1.45bn, est $1.36bn
- Enbrel rev $169mn, est $173.2mn
- Xeljanz revenue $321mn, -36% y/y, est $354.2mn
- Inlyta Rev $247mn, -2% y/y, est $244.2mn Adj.
- R&D expense $2.56bn, est $3.06bn
- Adj. SI&A expenses $3.22bn, estimate $3.42 billion
Comments
Cap, any updates on this ?
YuseeMo
2024-11-04 22:40:40 +0000 UTC
